Innoviva (INVA) Shares Outstanding (Weighted Average) (2016 - 2026)
Innoviva filings provide 17 years of Shares Outstanding (Weighted Average) readings, the most recent being $67.4 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 7.44% to $67.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.4 million, a 7.44% increase, with the full-year FY2025 number at $67.4 million, up 7.44% from a year prior.
- Shares Outstanding (Weighted Average) hit $67.4 million in Q4 2025 for Innoviva, down from $69.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $101.4 million in Q1 2021 to a low of $62.5 million in Q2 2024.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $67.6 million (2023), compared with a mean of $69.9 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 31.47% in 2021 and later grew 10.04% in 2025.
- Innoviva's Shares Outstanding (Weighted Average) stood at $82.1 million in 2021, then dropped by 15.13% to $69.6 million in 2022, then fell by 6.04% to $65.4 million in 2023, then fell by 4.14% to $62.7 million in 2024, then rose by 7.44% to $67.4 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $67.4 million (Q4 2025), $69.1 million (Q3 2025), and $62.8 million (Q2 2025) per Business Quant data.